Literature DB >> 16950441

Endovenous ablation of the great saphenous vein may avert phlebectomy for branch varicose veins.

Harold J Welch1.   

Abstract

BACKGROUND: Endovenous ablation of the great saphenous vein (GSV) may be performed simultaneously with stab phlebectomy of branch varicose veins or as a stand-alone procedure. A clinical approach of performing radiofrequency ablation (RFA) alone as initial treatment for varicose veins was reviewed.
METHODS: Patients with duplex ultrasound-documented reflux in the GSV and CEAP clinical stage 2 to 6 were selected for RFA. Patients were examined within a week preoperatively with duplex ultrasound imaging. Patients were seen within a week postoperatively and again at 2 to 3 months to ascertain if further treatment was required. A retrospective review of the initial 184 procedures in a series from June 2002 through February 2005 was performed, allowing for a 9-month follow-up period.
RESULTS: Three procedures were performed under general anesthesia and 181 with intravenous sedation and tumescent anesthesia. Postoperative duplex scans showed total occlusion or partial patency of <10 cm in 155 limbs. Seven (4.5%) had concomitant stab phlebectomy, seven subsequently had sclerotherapy, and 39 (25.2%) underwent subsequent stab phlebectomy of persistent symptomatic varicosities. In 101 limbs (65.1%), symptoms resolved and had no further therapy, and 24 limbs had a GSV that was patent for >10 cm on postoperative duplex imaging. Nine limbs had no further therapy (37.5%), eight (33.3%) had subsequent stab phlebectomy, and three had stripping of the GSV and stab phlebectomy. Four limbs had a redo RFA, four limbs had an aborted RFA procedure, and one limb was lost to follow-up. Failure of total GSV occlusion was more often associated with use of a 6F catheter. Complications were generally mild, and there was no postoperative deep vein thrombosis.
CONCLUSION: Endovenous ablation of the GSV can be performed safely and effectively as the initial treatment for lower extremity varicose veins. Because most patients show clinical improvement after RFA, an algorithm of reassessment of the limb and branch varicose veins several months post-RFA allows most patients to defer stab phlebectomy.

Entities:  

Mesh:

Year:  2006        PMID: 16950441     DOI: 10.1016/j.jvs.2006.06.003

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

1.  Treatment of varicose veins by transilluminated powered phlebectomy surgery: a 9-year experience.

Authors:  Randall W Franz; Jodi F Hartman; Michelle L Wright
Journal:  Int J Angiol       Date:  2012-12

2.  Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-02-01

3.  Randomized trial of radiofrequency ablation versus conventional surgery for superficial venous insufficiency: if you don't tell, they won't know.

Authors:  Cynthia de Almeida Mendes; Alexandre de Arruda Martins; Juliana Maria Fukuda; José Ben-Hur Ferraz Parente; Marco Antonio Soares Munia; Alexandre Fioranelli; Marcelo Passos Teivelis; Andrea Yasbek Monteiro Varella; Roberto Augusto Caffaro; Sergio Kuzniec; Nelson Wolosker
Journal:  Clinics (Sao Paulo)       Date:  2016-11-01       Impact factor: 2.365

4.  Endovenous Celon radiofrequency-induced thermal therapy of great saphenous vein: A retrospective study with a 3-year follow-up.

Authors:  Philippe Quehe; Zarrin Alavi; Tatiana Kurylo-Touz; Anne-Helene Saliou; Ali Badra; Laurent Baudino; Gurven Gladu; Frederik Ledan; Raphaël Haudebourg; Simon Gestin; Luc Bressollette
Journal:  SAGE Open Med       Date:  2018-08-21

5.  Current standards and recent progress in minimally invasive phlebo surgery.

Authors:  Oliver Göckeritz
Journal:  J Cutan Aesthet Surg       Date:  2012-04

Review 6.  Consensus for the Treatment of Varicose Vein with Radiofrequency Ablation.

Authors:  Jin Hyun Joh; Woo-Shik Kim; In Mok Jung; Ki-Hyuk Park; Taeseung Lee; Jin Mo Kang
Journal:  Vasc Specialist Int       Date:  2014-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.